COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1668: Articles 16671-16680  | Next

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
Byttebier, G., Belmans, L., Alexander, M., Saxberg, B. E. H., De Spiegeleer, B., De Spiegeleer, A., Devreker, N., Van Praet, J., Vanhove, K., Reybrouck, R., Wynendaele, E., Fedson, D.
10.1101/2021.03.24.21252687 — Posted: 2021-03-26 Discussion: Onsite
Dramatic drop of new SARS-CoV-2 infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 Vaccine
Guijarro, C., Galan, I. M., Perez-Fernandez, E., Martinez-Ponce, D. C., Goyanes, M. J., Castilla, V., Velasco, M.
10.1101/2021.03.24.21254238 — Posted: 2021-03-26
ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study
Iniguez, M., Perez-Matute, P., Villoslada-Blanco, P., Recio-Fernandez, E., Ezquerro-Perez, D., Alba, J., Ferreira-Laso, M. L., Oteo, J. A.
10.1101/2021.03.24.21253576 — Posted: 2021-03-26
Development and Evaluation of a new Swiss Made SARS-CoV-2 antigen-detecting rapid test
Ducrest, P. J.
10.1101/2021.03.25.21252280 — Posted: 2021-03-26
Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient
Klein, J., Brito, A. F., Trubin, P., Lu, P., Wong, P., Alpert, T., Pena-Hernandez, M. A., Haynes, W., Kamath, K., Liu, F., Vogels, C. B. F., Fauver, J. R., Lucas, C., Oh, J., Mao, T., Silva, J., Wyllie, A. L., Muenker, C., Casanovas-Massana, A., Moore, A. J., Petrone, M. E., Kalinich, C. C., IMPACT Research Team, , Cruz, C. D., Farhadian, S., Ring, A., Shon, J., Ko, A. I., Grubaugh, N. D., Israelow, B., Iwasaki, A., Azar, M. M.
10.1101/2021.03.24.21253992 — Posted: 2021-03-26
Pattern of COVID-19 epidemics in Japan influenced by the control measures
Konishi, T.
10.1101/2021.03.24.21253923 — Posted: 2021-03-26 Discussion: Onsite
Tenofovir-DF versus Hydroxychloroquine in the Treatment of Hospitalized Patients with COVID-19: An Observational Study (THEDICOV)
Cornejo-Giraldo, M., Rosado, N., Salinas, J., Aspilcueta, N., Bernales, E., Lipa, J., Coacalla, J., Flores, Y., Leon, P., Chambi, C.
10.1101/2021.03.24.21252635 — Posted: 2021-03-26
Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
Padoan, A., Dall'Olmo, L., Della Rocca, F., Barbaro, F., Cosma, C., Basso, D., Cattelan, A., Cianci, V., Plebani, M.
10.1101/2021.03.24.21254240 — Posted: 2021-03-26
Estimated Deaths, Intensive Care Admissions and Hospitalizations Averted in Canada during the COVID-19 Pandemic
Fisman, D., Tuite, A.
10.1101/2021.03.23.21253873 — Posted: 2021-03-26
Molecular beacons allow specific RT-LAMP detection of B.1.1.7 variant SARS-CoV-2
Sherrill-Mix, S., Van Duyne, G. D., Bushman, F. D.
10.1101/2021.03.25.21254356 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).